Document is current
Any future updates will be listed below
-
Authors
Siemiątkowska, Anna https://orcid.org/0000-0003-3568-4716
Kuźnar-Kamińska, Barbara https://orcid.org/0000-0001-7236-5023
Bryl, Maciej https://orcid.org/0000-0001-6873-5861
Kosicka-Noworzyń, Katarzyna https://orcid.org/0000-0003-3551-4784
Przybył, Paulina
Gołda-Gocka, Iwona
Główka, Franciszek K. https://orcid.org/0000-0002-6611-5789
-
Funding
Funding for this research was provided by:
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu (NMN0000060)
- License Information
-
More Information
Article History
Received: 6 June 2024
Accepted: 7 April 2025
First Online: 16 April 2025
Competing interests
: MB—honoraria, consulting or advisory role and travel, accommodations, expenses from Boehringer Ingelheim, Roche/Genentech, MSD, Bristol-Myers Squibb, AstraZeneca, Takeda, Novartis, Pfizer, Sanofi; AS, BKK, KKN, PP, IGG, and FKG declare no conflict of interests.
